The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Receptor heterodimerization leads to a switch in signaling: β‐arrestin2‐mediated ERK activation by μ‐δ opioid receptor heterodimers
Open accessAbstract
Opiates are analgesics of choice in the treatment of chronic pain, but their long‐term use leads to the development of physiological tolerance. Thus, understanding the mechanisms modulating the response of their receptor, the μ opioid receptor (μOR), is of great clinical relevance. Here we show that het‐erodimerization of μOR with δ opioid receptors (δOR) leads to a constitutive recruitment of β‐arrestin2 to the receptor complex resulting in changes in the spatiotemporal regulation of ERK1/2 signaling. The involve‐ment of β‐arrestin2 is further supported by studies using β‐arrestin2 siRNA in cells endogenously expressing the heterodimers. The association of β‐arrestin2 with the heterodimer can be altered by treatment with a combination of μOR agonist (DAMGO) and δOR antagonist (Tipp Ψ ), and this leads to a shift in the pattern of ERK1/2 phosphorylation to the pattern observed with μOR alone. These data indicate that, in the naive state, μOR‐δOR heterodimers are in a conformation conducive to β‐arrestin‐mediated signaling. Destabilization of this conformation by cotreatment with μOR and δOR ligands leads to a switch to a non‐β‐arrestin‐mediated signaling. Taken together, these results show for the first time that μOR‐δOR heterodimers, by differentially recruiting β‐arrestin, modulate the spatio‐temporal dynamics of opioid receptor signaling.—Rozenfeld, R., Devi, L. A. Receptor heterodimerization leads to a switch in signaling: β‐ar‐restin2‐mediated ERK activation by μ‐δ opioid receptor heterodimers. FASEB J. 21, 2455–2465 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Cited by
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Ferré, S., Casadó, V., Devi, L. A., Filizola, M., Jockers, R., Lohse, M. J., Milligan, G., Pin, J.-P., & Guitart, X. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008052 · Cited by 570
Self-citationCXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
Décaillot, F. M., Kazmi, M. A., Lin, Y., Ray-Saha, S., Sakmar, T. P., & Sachdev, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277038 · Cited by 333
Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill Children
Anand, K. J. S., Willson, D. F., Berger, J., Harrison, R., Meert, K. L., Zimmerman, J., Carcillo, J., Newth, C. J. L., Prodhan, P., Dean, J. M., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-0489 · Cited by 321
Vardanyan, R. S., & Hruby, V. J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.215 · Cited by 293
Metadata
- Authors
- Rozenfeld, R., & Devi, L. A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-03-23
- Volume
- 21
- Issue
- 10
- Pages
- 2455-2465
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2073771628
- Cited by
- 220
- References
- 1
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Receptor heterodimerization leads to a switch in signaling: β‐arrestin2‐mediated ERK activation by μ‐δ opioid receptor heterodimers. https://app.cochat.ai/papers/10.1096/fj.06-7793com
- The paper
- Rozenfeld, R., & Devi, L. A. (2007). Receptor heterodimerization leads to a switch in signaling: β‐arrestin2‐mediated ERK activation by μ‐δ opioid receptor heterodimers. The FASEB Journal. https://doi.org/10.1096/fj.06-7793com
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.